Key facts
- In February 2026, 11 EU/EEA countries reported 139 measles cases. Fifteen countries reported zero cases.
- During the last 12-month period, six deaths attributable to measles were reported to ECDC by France (4), Romania (1) and the Netherlands (1).
- Overall, case numbers decreased compared with previous month.
- Complementary epidemic intelligence surveillance was performed on 15 and 16 April 2026. Outbreak has been reported in Bulgaria and Latvia. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA.
Overview
In February 2026, 26 countries reported measles data. Eleven countries reported 139 cases and 15 countries reported zero cases.
Overall, case numbers decreased compared with the previous month, however this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Italy (63), Spain (36), France (16) and Poland (five).
Between 1 March 2025 to 28 February 2026, 30 EU/EEA Member States reported a total of 4 623 cases of measles, 3 860 (83.5%) of which were laboratory confirmed.
Of the 4 623 cases with known age, 1 536 (33.2%) were in children under five years; 1 956 (42.3%) cases were in those aged 15 years or above. The highest notification rates were observed among infants under one year of age (124.0 cases per million) and children aged 1-4 years (65.3 cases per million).
Of 4 013 individuals (86.8% of all cases) with a known age and vaccination status, 3 206 (79.9%) were unvaccinated, 378 (9.4%) were vaccinated with one dose of a measles-containing vaccine, 386 (9.6%) were vaccinated with two or more doses, and 34 (0.8%) were vaccinated with an unknown number of doses.
During the 12-month period, six deaths (case fatality rate (CFR): 0.130 %) attributable to measles were reported to ECDC by France (four), Netherlands (one) and Romania (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance was performed on 15 and 16 April 2026. Outbreak has been reported in Bulgaria. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA. Outside the EU/EEA, updates have been provided England, Bangladesh, Ukraine, Africa CDC,the World Health Organization Pan American Health Organization (WHO PAHO), Canada, US, Mexico, Indonesia and Japan.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported four confirmed or probable cases in 2026 and as of 8 April 2026.
Bulgaria reports an outbreak of measles with 104 cases reported as of week 15 in 2026. According to media report, quoting health authorities on 10 April 2026, most of the cases are reported in Vratsa region (n=80), followed by Pleven (n=12), Lovech (n=6), Sofia city (n=2) and Sofia region (n=1). Eleven cases are adults between 19 and 53 years of age. More than half of the total cases were unvaccinated. Over 13 000 MMR vaccine doses have been administered in response to the outbreak. In 2025, Bulgaria reported two cases.
France reported 28 cases and no deaths in January and February 2026. The cases were
related to three clusters and are detected mainly among children. Thirteen departments in France (13%) reported at least one case during the period. No cases have been reported in the Overseas Territories. The five main departments with the most reported cases are: Paris (18%), Essonne (18%), Hauts-de-Seine (18%), Savoie (11%) and Bouches-du-Rhône (7%). Fifteen cases were related to five clusters.
Germany reported 59 confirmed and probable measles cases in 2026 (week 1 to 15), an increase of 21 cases since week 10. No outbreaks have been detected by ECDC EI group.
Ireland reported 10 cases in 2026 in weeks 1 to 14. Data from Ireland (National Notifiable Disease Hub) includes confirmed, probable, and possible measles cases.
Latvia reported the first outbreak of measles since 2018 (Weekly Communicable Disease Threats Report w13). Since the start of the outbreak in March 2026, 47 cases have been reported (43 laboratory confirmed) (as of 15 April 2026). Over a thousand contacts have been identified and followed-up. Most of the cases are unvaccinated children. All cases are epidemiologically linked. The most recent case was reported on 4 April 2026. Genotype D8 was detected in the first 10 samples. A previous measles outbreak in Latvia was reported in 2018 (n=25), followed by two sporadic imported cases in 2023 and in 2025. According to Latvian authorities due to decreased vaccination rates in some of the regions, around 4% of 1 to 17-year-old children are not vaccinated. The national authorities asses the risk as moderate to high, especially among non‑immune people.
Poland reported 12 cases of measles from 1 January to 31 March 2026.
Portugal reported, two confirmed unrelated cases of measles in an unvaccinated child and an adult (media report quoting health authorities on 6 April 2026)
Spain reported 97 cases of measles from 1 January to 12 April 2026, including 7 imported and 7 cases related to imported cases. This represents an increase of 12 cases since March 2026.
Sweden reported four cases in 2026 and as of 15 April 2026.
Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:
No new outbreaks or cases have been detected in the reporting period.
Western Balkan countries and Türkiye
No new outbreaks or cases have been detected in the reporting period.
Epidemiological summary for selected countries outside of the EU/EEA with relevant epidemic intelligence updates:
Ukraine reported 56 cases in January and February 2026. In addition, media reported on 16 April 2026, 121 cases of measles were reported in Ivano-Frankivsk region in 2026 with 84% of cases in children. In 2025, Ukraine reported 1 502 measles cases from January to December 2025.
England reported 371 laboratory confirmed cases and no deaths, between 1 January and 6 April 2026. The majority of cases – 69% - involve children under 10 years of age and 26% were young people and adults 15
years or older. Geographically, 57% of the case have been reported in London, followed by 24% in West Midlands and 7% in North West.
Bangladesh is experiencing a sharp increase in measles transmission, with 9 883 suspected cases reported nationwide as of 7 April 2026, including 1 398 laboratory-confirmed cases and at least 128 suspected deaths (21 confirmed). Children under five years of age are mostly affected - 81% of all cases, including 34% among infants under nine months of age who are not yet eligible for routine measles-containing vaccination. Most cases have been reported among unvaccinated (72%) or under-vaccinated children (16%). There are depleted national MMR stocks that constrain both, national immunization plan and outbreak response. Health facilities are reported to be under severe strain, with overcrowding, limited triage and isolation capacity, and shortages of critical medical supplies. In response, on 5 April 2026 UNICEF and partners supported the Government of Bangladesh to launch an emergency measles–rubella vaccination campaign targeting 18 high-burden districts, alongside parallel measures to provide vitamin A supplementation, strengthen health facility capacity, procure essential supplies and reinforce community engagement to interrupt transmission.
Africa CDC reported on 13 April 2026, overall, in 2026, there have been reported 1 603 confirmed and 50 252 suspected cases of measles and 388 deaths from 18 AU MS countries. High risk of measles spread is listed for Mali and Senegal, and moderate risk in Malawi and Mozambique.
According to the WHO Pan American Health Organization (WHO PAHO) report published on 28
March, 14 465 confirmed measles cases have been reported by 10 countries, of which the majority of cases are reported in Mexico (8 315), Guatemala (3 687), the United States (1 664), and Canada (733). Due to the upcoming FIFA World Cup 2026 more detailed overview is provided for the hosting countries: Canada, Mexico and US.
Canada reported 789 measles cases (724 confirmed) and no deaths across 7 jurisdictions in 2026 and as of 4 April 2026. The country remains in active transmission across multiple provinces due to ongoing multijurisdictional outbreak, the vast majority of the cases reported in 2026 are linked to this outbreak.
The US continues to face multiple concurrent outbreaks, including several that began in 2025 and continue into 2026. Overall US CDC reported 1 714 cases and no deaths between January and 9 April 2026 (vs a total of 2 287 cases, including 3 deaths in 2025). In the same period there were new 17 outbreaks reported and 94% of confirmed cases are outbreak associated. Majority of the cases are children (73%) and unvaccinated individuals (92%).
Mexico reported on 15 April 2026, overall since the beginning of the outbreak in 2025, 15 945 confirmed cases were reported, including 36 deaths. In 2026, Mexico reported 9 458 confirmed cases and nine deaths. The number of cases is declining after a peak reported in week 6 in 2026. Mostly affected state in 2026 remains Jalisco (3 823 cases; three deaths).
Indonesia reported 8 810 suspected measles cases, 572 laboratory‑confirmed cases (about 67% of which had no immunization history), and five deaths during January–February 2026. According to media report, Ministry of Health declared an Extraordinary Event for measles in 7 areas in South Sulawesi province, following a national spread of measles since the December 2025.
Japan faces an increase of measles cases in 2026 with 236 cases reported in weeks 1-14, the number of cases similar to total reported in a whole year of 2025 (n=265). Preliminary data suggest 72% of the cases are teenagers and adults: 22% are 15-19 year-olds, 28% are 20-29-year-old, 22% are 30-39-year-olds, followed by 14% of 40-49 year-old individuals. in the reporting period, 30 cases were imported and 159 are considered as domestic cases. Of the imported cases, 12 were travellers from Indonesia and 7 from New Zealand.
For more information on the provisional number of cases outside the EU/EEA region, please visit the World Health Organization (WHO) website.
The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.
Continued vigilance is essential due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, possible introduction from areas with ongoing transmission, and increased travel and population movement during holiday periods.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs of measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.
ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for measles-containing vaccines (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with populations underserved by healthcare services. Systemic barriers that affect vaccine uptake in populations that are isolated and underserved by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
- In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up-to-date with recommended immunisations prior to departure.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.